XRTX

0.83905.73%
AW

Allen Warren Davidoff

Founder, Co-CEO, President & Director

Dr. Allen Warren Davidoff, Ph.D. is Founder of XORTX Therapeutics Inc. (formerly known as XORTX Pharma Corp.) and has been its President since January 9, 2018 and as its Co-Chief Executive Officer from June 2026. Dr. Davidoff was Chief Executive Officer of XORTX Therapeutics Inc. since January 9, 2018 until June 2026. Dr. Davidoff served as the Chief Scientific Officer and co-Founder of Stem Cell Therapeutics Corp. from December 31, 2010 to March 2012 and also served as its Vice President of Product Development from November 2004 to December 2011. From September 2003 to December 2004, Dr. Davidoff served as Senior Clinical Scientist of Cardiome Pharma Corp. From September 2002 to March 2003, Dr. Davidoff served as Biotechnology Analyst for Lightyear Capital Inc., an investment dealer. His overall experience includes drug development experience with broad clinical and regulatory leadership experience. His senior management experience in pharmaceutical R&D includes two investigational new drug (IND) applications or supplemental IND’s, two phase I studies (four multi-country), seven phase II studies and one NDA. He serves as a Director of XORTX Therapeutics Inc. (formerly known as XORTX Pharma Corp.) since January 9, 2018. He serves as a Director of Patient Stem Cell Resource Inc. Dr. Davidoff served as Director of Neurogenesis. Dr. Davidoff holds a Ph.D. degree in Cardiovascular Physiology from the University of Calgary.

Positions